Patent · US Active

Complexes of RNA and cationic peptides for transfection and for immunostimulation

US10111967B2 · kind B2 · utility

22Cited by
30References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 29, 2013
Grant dateOct 30, 2018
Priority date
Expiry dateApr 28, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/53
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a complexed RNA, comprising at least one RNA complexed with one or more oligopeptides, wherein the oligopeptide, which has the function of cell-penetrating peptide (CPP), has a length of 8 to 15 amino acids and has the empirical formula (Arg)l;(Lys)m;(His)n;(Om)o;(Xaa)x with the majority of residues being selected from Arg, Lys, His, Om. The invention further relates to a method for transfecting a cell or an organism, thereby applying the inventive complexed RNA. Additionally, pharmaceutical compositions and kits comprising the inventive complexed RNA, as well as the use of the inventive complexed RNA for transfecting a cell, tissue or an organism and/or for modulating, preferably inducing or enhancing, an immune response are disclosed herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.